Expression of HIF-1α and Glut-1 in human bladder cancer

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 909-913

  Palit, Victor ^a,b   Phillips, R M ^a   Puri, R ^b   Shah, T ^b   Bibby, M C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bladder cancer; Glut 1; HIF 1

Indexed keywords

GLUCOSE TRANSPORTER 1; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY; OXYGEN;

ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CANCER INVASION; CELL NUCLEUS; CHEMISTRY; CYTOPLASM; DIMERIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PROGNOSIS; STATISTICAL MODEL; TREATMENT OUTCOME; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DIMERIZATION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; OXYGEN; PROGNOSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33644819081     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.909     Document Type: Article

References (11)

1. Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia inducible factor 1 is a basic loop helix- PAS heterodimer regulated by oxygen tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
2. Wang GL and Semenza GL: Purification and characterisation of Hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
3. Jones A, Fujiyama C, Blanche C, Moore JW, Figgle S, Bicknell R and Harris AL: Relation of vascular endothelial growth factor production to expression and regulation of Hypoxia-inducible factor 1α and Hypoxia-inducible factor 2α in human bladder tumour and cell lines. Clin Cancer Res 7: 1263-1272, 2001. (Pubitemid 32708679)
4. Younes M, Lechago L, Somoano J, et al: Wide expression of human glucose erythrocyte Glut-1 in human cancers. Cancer Res 56: 1164-1167, 1996. (Pubitemid 26065417)
5. Younes M, Lechago LV, Juarez D and Lerner SP: Glut-1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res 21: 575-578, 2001. (Pubitemid 32267574)
6. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M and Semenza GL: Cellular and developmental control of oxygen homeostasis by Hypoxia inducible factor la. Genes Dev 12: 149-162, 1998. (Pubitemid 28060446)
7. Juarez D, Younes M, Lechago LV, et al: Glut-1 expression in transitional cell carcinoma of the urinary bladder correlates with aggressive biologic behaviour. US Can Acad Pathol 75A; 429, 1996.
8. Theodoropoulos VE, Lazaris AC, Kastriotis I, et al: Evaluation of hypoxia-inducible factor 1α overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU Int 95: 425-431, 2005. (Pubitemid 40283138)
9. Hoskin PJ, Sibtain A, Daley FM and Wilson GD: GLUT-1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 89: 1290-1297, 2003. (Pubitemid 37363419)
10. Aebersold DM, Burri P, Beer KT, et al: Expression of hypoxia-inducible factor 1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal carcinoma. Cancer Res 60: 4693-4596, 2001.
11. Unruh A, Ressel A, Mohamed HG, et al: The hypoxia-inducible-factor- 1α is a negative factor for tumour therapy. Oncogene 22: 3213-3220, 2003. (Pubitemid 36712933)